Sickle-cell anemia treatment

NEW YORK, July 24 (Praxis Press) Previous reports have documented that sodium cromoglicate has antisickling activity in vitro. Toppet and colleagues studied this antisickling activity in sickle-cell patients given sodium cromoglicate by inhalation or nasal route. Both treatments significantly decreased the percentage of sickle cells in venous blood; this effect was largely retained when the blood was deoxygenated. Sodium cromoglicate may be a clinically useful antisickling drug that has the adde

July 25, 2000

NEW YORK, July 24 (Praxis Press) Previous reports have documented that sodium cromoglicate has antisickling activity in vitro. Toppet and colleagues studied this antisickling activity in sickle-cell patients given sodium cromoglicate by inhalation or nasal route. Both treatments significantly decreased the percentage of sickle cells in venous blood; this effect was largely retained when the blood was deoxygenated. Sodium cromoglicate may be a clinically useful antisickling drug that has the added benefits of low toxicity and low cost.

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. Genetic Analysis Reveals the Evolutionary History of Dogs
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS